For the development of this drug for DED to date the company has completed:
Ocular irritation studies Proof of concept pre-clinical DED trials for efficacy Confirmatory pre-clinical DED trials for efficacy Pilot drug stability (ie. shelf-life) testing Pilot tolerability and toxicology studies All these studies were conducted by market-leading contract research organizations (CRO).